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INTRODUCTION
Remodeling is a normal adaptive process in
response to changes in hemodynamic conditions and
might contribute to the pathophysiology of vascular
disease. Pressure-dependent wall stress and flow-
dependent shear stress interact and regulate vessel
wall thickness and lumenal diameter.1–4 In response
to increased blood flow, the lumen increases, and
lumen conversely decreases in response to low
flow.5–7 Changes in flow and shear stress also modi-
fy the lumenal caliber by regulating intimal thick-
ness. In endothelialized polytetrafluoroethylene
(PTFE) grafts implanted in baboons, a switch from
high to normal blood flow induces proliferation of
neointimal SMCs and an increase in neointimal
area.8 On the other hand, increased blood flow dur-
ing graft healing inhibits the development of neoin-
timal hyperplasia, and a switch from normal to high
flow causes an established neointimal thickening to
regress.9,10 These vascular substitutes are relatively
rigid. Because PTFE grafts cannot contract or dilate,
changes in lumenal size are regulated entirely by
changes in intimal area.
Because intimal mass and vasoconstriction both
contribute to lumenal narrowing, it is possible that
vessel wall growth and vasomotor function are con-
trolled by similar factors. Furthermore, because the
endothelium is able to detect changes in shear stress,
it might regulate lumenal diameter by generating
biochemical signals that control SMC growth and
contractile state. Cellular growth and intimal thick-
ening are often viewed as events driven by growth
promoting factors. It is equally likely that prolifera-
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tion of SMCs is the consequence of decreased
growth inhibition. One such inhibitory endothelial
signal is nitric oxide (NO) generated by the enzy-
matic activity of constitutive endothelial nitric oxide
synthase (cNOS). NO is a major physiological regu-
lator of basal vascular tone and diameter.11 In phar-
macological concentrations, NO also inhibits the
growth of SMCs in vitro and in vivo.12–14 We
hypothesized that a decrease in shear stress in pri-
mate arteries would decrease vascular diameter
through vasoconstriction and increased SMC
growth and that changes in NO originating from the




In the initial studies, we made use of material
obtained as part of an earlier experiment.8 We mea-
sured SMC proliferation in the external iliac arteries
of baboons (Papio cynocephalus) subjected to aorto-
common iliac bypass grafting. The observations on
the neointimal thickening response in the grafts have
already been reported.8 Anesthesia was induced in
young male baboons (Papio cynocephalus) with intra-
muscular ketamine hydrochloride (10 mg/kg) and
was maintained with halothane. The animals were
anticoagulated with heparin intravenously (100
U/kg, Elkins-Sinn, Inc., Cherry Hill, NJ) and cefa-
zolin (25 mg/kg/im, Bristol-Meyers Squibb,
Princeton, NJ) was administered. Bilateral PTFE
grafts (unwrapped, 4 mm internal diameter, 6–8 cm
long, internodal distance 60 m m, W.L. Gore and
Associates, Inc., Flagstaff, Ariz) were implanted
between the aorta and the common iliac arteries in
an end-to-side fashion using 6-0 polypropylene
suture (Davis and Geck, Danbury, Conn). The
native vessels were ligated to divert all flow down to
the lower extremity through the grafts and external
iliac arteries. Bilateral arteriovenous fistulas 10 mm
long were constructed between each femoral artery
and vein in the groins to generate high flow through
the proximal grafts and external iliac arteries. Two
months later, the fistula on one side was ligated to
restore normal flow. The contralateral side remained
under high flow. The animals were euthanized by
barbiturate overdose 1 day, 2 days, 4 days, 7 days, 14
days, or 28 days after fistula ligation, and the iliac
arteries perfusion fixed at a pressure of 100 mm Hg
with 10% neutral buffered formalin after irrigation
with lactated Ringer’s solution. These animals
received (3H) thymidine (0.5 mCi/kg per dose,
New England Nuclear, Boston, Mass) intramuscu-
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larly 17 hours, 9 hours, and 1 hour before being
killed. In these experiments, the grafts and iliac
arteries were processed and embedded in paraffin,
and histologic cross-sections were prepared. The
sections were dipped in Kodak NTB-2 emulsion and
exposed at 4°C for 2 weeks. After development in
Kodak D19, slides were counterstained with hema-
toxylin. SMC proliferation (thymidine labeling
index) was determined by dividing the number of
labeled nuclei by the total number of nuclei per sec-
tion and multiplying by 100.
In subsequent studies, bilateral arteriovenous fis-
tulas were constructed in the absence of the PTFE
aortoiliac grafts. At 2 months, one of the 2 fistulas
was ligated in each animal. Tissue was then retrieved
at various times for histology, NO measurements,
and Northern analysis to measure SMC proliferation
after the animals had received bromodeoxyuridine
(BrdU, Boehringer Mannheim) 30 mg/kg per dose
intramuscularly 17 hours, 9 hours, and 1 hour
before being killed. External iliac arteries were
removed 1 day, 4 days, and 21 days after fistula li-
gation. Two segments from the midportion of each
artery were fixed in methyl Carnoy’s or formalin fix-
ative for immunohistochemistry and morphometry.
The remaining tissue was added to denaturing solu-
tion D (4 mol/L guanidinium thiocyanate, 25
mmol/L sodium citrate, pH 7.0, 0.5% sarcosyl, and
0.1 mol/L 2-mercaptoethanol), homogenized, and
stored at –70°C for later analysis of mRNA.
NOS Blockade
To investigate whether inhibition of cNOS at
high blood flow could mimic the biological effects
seen after fistula ligation, we locally infused the
competitive nitric oxide synthase inhibitor (N w -
nitro-L-arginine (L-NA, Sigma). Bilateral femoral
arteriovenous fistulas were placed in 6 animals for 1
week and in 10 animals for 2 months. At the end of
these intervals, all animals received local infusion
devices consisting of Silastic catheters connected to
short segments of PTFE graft implanted upstream
from both external iliac arteries.15 L-NA w (4.5
mg/h) was delivered on one side and saline on the
other for 4 days. This dose of L-NA was selected
based on the reported experience of Yukimura et
al16 and our own calculation of boundary layer con-
centration.17 Assuming a blood flow rate of 8
mL/sec, this dose should yield a concentration of
0.5 mmol/L. Kuchan and Frangos18 have shown
that 0.1 mmol/L is sufficient to abrogate NO pro-
duction by human endothelial cells. 
All animal care and procedures were performed
at the University of Washington Regional Primate
Center in accordance with state and federal laws.
Animal protocols were approved by the University
of Washington Animal Care Committee and con-
formed to guidelines set forth by the American
Association for Accreditation of Laboratory Animal
Care and by the National Institutes of Health (pub-
lication number 86-23, “Guide for the Care and Use
of Laboratory Animals”).
Measurement of blood flow
Blood flow was monitored with Duplex scanning
(Acuson 128) while the animals were under keta-
mine sedation. The iliac arteries were examined both
before and 1 week after graft implantation, as well as
immediately before and after unilateral fistula clo-
sure and just prior to necropsy. Mean shear stress
was calculated according to the modified Hagen-
Poiseuille equation: t = 4h Q/ p r3, where h is blood
viscosity (0.035 poise), Q is volume flow (mL/s),
and r is the vessel radius in centimeters.
Immunohistochemistry
Immunohistochemistry was performed on sec-
tions of paraffin-embedded tissue with antibodies
directed against smooth muscle a -actin (Boehringer
Mannheim, Indianapolis, Ind), cNOS, (Transduction
Lab, Lexington, Ky), BrdU (Boehringer Mannheim),
and Von Willebrand factor (vWF) (Dako Corp.,
Carpenteria, Calif). The sections were incubated for 1
hour at room temperature (BrdU, vWF, a -actin) 
or overnight at 4°C (cNOS) with the primary anti-
body. Biotinylated secondary antibodies (Vector
Laboratories, Inc., Burlingame, Calif), avidin-biotiny-
lated peroxidase, and diaminobenzidine/NiCl2 were
used as the chromogen, and methyl green was used as
the counterstain for nuclei.
Northern analysis
Total RNA was extracted as described by
Chomczynski and Sacchi.19 The samples were separat-
ed by electrophoresis and transferred to nylon blotting
membranes (Zeta-Probe, Bio-Rad). Complementary
DNA (cDNA) probes for the human cNOS and the
inducible isoform of NOS (iNOS) were labeled with
32P by nick translation, added to the hybridization
solution (0.15 mol/L Na2HPO4 pH 7.2, 0.28 mol/L
NaCl 7.8% SDS, 1mmol/L EDTA, 50% formamide,
10% polyethylene glycol, and 200 mg/mL of dena-
tured salmon sperm DNA), and incubated at 42°C for
20 to 24 hours. Signals were quantitated by phosphor
imaging and normalized to 28 S ribosomal RNA. The
cDNA clones used to generate probes were confirmed
by sequence analysis and hybridization to 4.3 kilobase
(kb) transcripts in cultured baboon endothelial cells
(cNOS) and SMCs stimulated by cytokines (iNOS)
(data not shown).
Nitric Oxide Analysis
Nitric oxide was measured as total nitrogen
oxides (NOx) by ozone chemiluminescence in con-
ditioned medium of excised vessel segments incu-
bated for 1 hour at 37°C in a modified Krebs Hepes
buffer containing the calcium ionophore A23187, as
previously described.20 The production was normal-
ized to nmol/mL buffer/mg dry weight of the
artery wall.
Statistical analysis
Comparisons were made with Wilcoxon’s
matched pair signed rank test. P < .05 was consid-
ered statistically significantly different. Data are
expressed as mean ± SD.
RESULTS
The lumenal diameter in external iliac arteries
measured by ultrasound increased from 2.8 ± 0.1 to
4.4 ± 0.4 mm (n = 4) at 2 months after construction
of the femoral arteriovenous fistulas in animals with-
out PTFE grafts. Four days after unilateral fistula li-
gation, the ipsilateral arteries constricted to 3.4 ±
1.0 mm. The shear stress increased 6-fold (9 ± 7 vs.
51 ± 24 dynes/cm2) with the fistula in place and
decreased nearly to baseline (13 ± 2 dynes/cm2)
after the fistula was ligated. The arteries remaining
under high shear stress did not demonstrate any
changes in diameter. The mean blood pressure gra-
dient was measured between the aorta and the
femoral artery and was 3 mm Hg on the side with
reduced flow and 6 mm Hg on the side with high
flow. On day 4, SMC proliferation, as measured by
means of BrdU labeling in the intima of the external
iliac arteries subjected to flow switch, was increased
(normal flow [fistula ligated]: 2.7% ± 1.5%; high
flow: 0.1% ± 0.1%; n = 3). Similar observations were
made in external iliac arteries located distal to PTFE
grafts and subjected to fistula ligation (flow switch)
at 2 months. SMC proliferation was increased by day
4 (normal flow [fistula ligated]: 0.8% ± 1.6%; high
flow: 0.1% ± 0.2%; n = 4; P = ns) and day 7 (normal
flow: 1.2% ± 1.5%; high flow: 0.1% ± 0.3%; n = 7; P
< .05). Vasocontraction was detected by ultrasound
in the external iliac arteries subjected to flow switch
at 4 days (normal flow: 2.1 ± 0.5 mm2; high flow:
4.4 ± 1.8 mm2), but not earlier.
The changes in diameter and SMC proliferation
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were preceded on day 1 by a marked decrease in
cNOS mRNA (Fig. 1). The decrease in cNOS
mRNA was reflected in a decrease in cNOS protein
in the endothelium at 4 days, as detected by means
of immunohistochemistry. On day 1, when no bio-
logical effects were present, no difference in protein
was seen (Fig. 2). The iNOS could not be detected
at any of the intervals studied (data not shown).
To define further the role of NO in the flow-
dependent changes in vessel diameter and SMC pro-
liferation, we performed experiments in which the
NOS inhibitor, L-NA, was infused locally in one of
the iliac arteries and saline in the other. In the animals
in which L-NA and saline were administered begin-
ning 7 days after fistula placement, the external iliac
arteries between 0 cm and 4 cm downstream of the L-
NA infusion devices contracted, whereas the control
infusion vessels did not (L-NA: 2.3 ± 0.3 mm, saline:
4.2 ± 0.2 mm). On the other hand, L-NA infusion
started at 2 months after fistula placement did not
cause contraction. SMC proliferation was not signifi-
cantly different in the L-NA treated vessels (Table I).
In the sections taken from the segment of vessel adja-
cent to the infusion device, SMC proliferation was
increased in some, but not all, animals (Table 1). The
L-NA treated arteries demonstrated a 3-fold decrease
in NOx production when analyzed ex vivo immedi-
ately upon killing (0.1 ± 0.1 vs. 0.33 ± 0.4 nmol/mL
buffer/mg dry weight; n = 4).
DISCUSSION
In earlier studies, we showed that increased blood
flow and shear stress suppresses neointimal thicken-
ing in baboon aortoiliac PTFE grafts and that
restoration of flow to normal (flow switch) generates
a signal for SMC growth and neointimal hyperpla-
sia.8,9 We now demonstrate that iliac arteries subject-
ed to flow switch after a 2-month period of high
blood flow exhibit some of the same changes as the
PTFE grafts. SMC proliferation was induced after a
lag of several days. In addition, the arteries contract-
ed within 4 days after fistula ligation. Because the
decline in cNOS and NO preceded the vascular con-
traction and onset of SMC proliferation, the change
in cNOS and NO might be the critical molecular
event for the initiation of SMC growth. However, L-
NA infused just upstream failed to induce SMC pro-
liferation or vasocontraction in the chronic high flow
arteries, even though it inhibited cNOS and caused
arterial contraction early after fistula placement. On
the other hand, NO infused locally inhibits SMC
proliferation in balloon-injured arteries.15 These
observations indicate to us that NOS blockade might
be necessary, but it is not sufficient for SMC growth,
and it is likely there are other growth inhibitors and
mitogens (eg, COX-2/PGI2, PDGF-B) responsive
to changes in blood flow that are required.21–27
The vascular response to changes in blood flow
In normal large arteries, increased blood flow
induces vasodilation, and decreased flow induces
vasoconstriction. These changes in diameter proba-
Fig. 1. A, Northern blot of total RNA from aortas, high
flow arteries (HF), and arteries at 1, 4, and 21 days after
fistula ligation (NF) probed for cNOS. B, The blots were
probed for 28 S ribosomal RNA to normalize for loading.
The data for cNOS in NF arteries at various times after fis-
tula ligation (flow switch) are expressed as percent of
cNOS in HF arteries (mean ± SD; at day 1, n = 4; at day
4, n = 5; at day 21, n = 2). The differences at 1 day and 4
days between NF and HF arteries are significant. 
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bly occur to keep shear stress relatively constant (ca
15 dynes/cm2). Theoretical calculations and experi-
mental studies in animals and humans have suggest-
ed that an optimally designed arterial circulation is
characterized by a constant shear stress of this mag-
nitude.28–30 Although the usual response to changes
in blood flow and shear stress is vessel contraction or
relaxation, in certain pathological states the lumen
can also be altered by changes in wall mass. The
potential for reduced shear stress to increase intimal
mass has been documented in human atherosclerot-
ic arteries, synthetic grafts, and arterialized vein
grafts.9,31–33 In our baboon graft experiments,
increased neointimal thickening is a prominent fea-
ture of the response to a switch from high to normal
flow, perhaps because vasoconstriction is not possi-
ble in these rigid conduits.8,9 In the adjacent, rela-
tively normal iliac arteries, the response is primarily
vasoconstriction associated with a slight increase in
intimal thickening (data not shown). The response
to increased shear stress is vasodilation and, at times,
vascular atrophy.3,34,35 As atherosclerotic plaque
Table I. Effect of local infusion of L-NA on SMC proliferation (%) in iliac arteries
Distance from infusion device # of animals
Intima Media
(cm) (N) NaCl L-NA NaCl L-NA
1 10 7.8 ± 8.1 12.9 ± 9.2 1.2 ± 1.8 1.5 ± 2.5
2 9 7.2 ± 8.1 3.0 ± 4.4 0.4 ± 0.4 0.2 ± 0.3
3 7 2.2 ± 4.8 1.9 ± 1.7 0.2 ± 0.3 0.2 ± 0.4
Infusion devices were inserted in both proximal external iliac arteries at 2 months after placement of femoral arteriovenous fistulas. 
L-NA was infused on one side and carrier medium on the other. The perfusion-fixed vessels were removed at 4 days and SMC prolifer-
ation (BrdU labeling index; mean ± SD) analyzed on cross-sections taken at intervals downstream from the infusion devices. Differences
are not significant.
Fig. 2. Histological cross-sections of high flow (A and C) and normal flow (B and D) iliac
arteries stained for cNOS at 1 day (A and B) and 4 days (C and D) after unilateral fistula li-
gation. Arrow indicates endothelial layer. Bar = 10 m m.
FPO
grows, the diseased artery compensates by dilating
in an attempt to keep shear stress constant. Because
the lesion is frequently asymmetrically distributed
about the circumference, the normal portion of the
vessel and the media underlying the plaque can atro-
phy. In the baboon grafts, a switch from normal to
high flow is associated with a decrease in neointimal
mass and a loss of both SMCs and matrix.10
Endothelial Mechanotransduction
The vasomotor responses to flow of conduit vessels
are largely abolished when the artery is denuded of
endothelium.1,4,36,37 The endothelium is probably the
sensor of shear stress and responds by generating bio-
chemical signals that affect SMC contraction, growth,
or both. In general, endothelial factors that stimulate
contraction also stimulate SMC growth (eg,
angiotensin II, endothelin, PDGF) and vice versa.38–40
There is a similar relationship between relaxation and
growth inhibition (eg, cNOS/NO, COX-2/prostacy-
clin).12,26,41 The expression of these factors by cultured
endothelium is regulated by fluid shear. cNOS, for
example, is induced and endothelin is suppressed by
shear stress.23,42 However, the results of in vitro exper-
iments sometimes are at variance with those of in vivo
experiments. cNOS, PDGF-A, and PDGF-B are all
induced by shear stress in vitro.21,23,24 We have
observed increased cNOS and decreased PDGF-A and
PDGF-B chain expression in high flow grafts27 and iliac
arteries, and a reversal of this pattern when the flow is
switched from high to normal (Fig. 1 and unpublished
observations). The reasons for the differences between
the cell culture and animal experiments are not yet evi-
dent, but might have to do with experimental design.
The cell culture experiments usually are conducted over
short periods (0–48 hours) and focus on gene expres-
sion in response to fluid shear stress (a switch from no
shear to some shear), whereas our in vivo experiments
are conducted over a longer period and study the
effects of a switch from high to normal shear stress.
The mechanism by which endothelial cells sense
shear and transduce the mechanical stimulus into a
biochemical response is under intense study in a
number of laboratories.43,44 The different shear-
responsive genes might be induced by a common
pathway involving certain transactivating factors and
cis-acting response elements. The first shear stress
response element (SSRE) was discovered in the ‘5-
flanking region of the PDGF-B gene.21,45 The
human, and presumably baboon, cNOS genes con-
tain this SSRE. Other SSREs have been reported. It
is not known whether these SSREs control gene
expression in endothelium in vivo. 
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cNOS, NO, and SMC Proliferation
Because the decrease in cNOS preceded the con-
traction of the iliac artery and the increase in SMC
proliferation, we thought that changes in NO might
be a major factor in determining SMC growth state.
The results from a number of cell culture and animal
experiments provide support for this hypothesis. NO
delivered by inhalation, by intravenous infusion, or
by local gene expression inhibits intimal thickening
after balloon injury.13,14,46 The administration of L-
arginine, the precursor of NO, inhibits intimal
hyperplasia and retards atherosclerosis.47–51 It also
affects a number of other events linked to the injury
response, including platelet adhesion and aggrega-
tion and leukocyte adhesion.52,53 NO can suppress
endothelial and SMC growth and migration in
vitro.12,54,55 NOS blockade promotes atherosclero-
sis in rabbits and can increase intimal thickening
after injury under certain circumstances.56 Increased
blood flow suppresses injury-induced intimal thick-
ening in the carotid arteries of rats; in this circum-
stance, NOS blockade inhibits the effect of high
blood flow, although it has no effect on injury-
induced intimal thickening in vessels with normal
blood flow.57–59
Why does NOS blockade fail to induce SMC
proliferation, even though the switch from high to
normal blood flow stimulates SMC growth and inti-
mal thickening in baboon iliac artery? Although
there is no definitive answer, there are some intrigu-
ing possible explanations. One possibility is that
there are other inhibitors of SMC growth that are
expressed in an artery subjected to abnormally high
blood flow. Because L-NA caused vasoconstriction
in iliac arteries at 1 week after fistula placement but
not at 2 months after fistula placement, it is likely
that other inhibitors of vasoconstriction were pre-
sent. COX-2 is induced by increased shear stress in
endothelial cells and could be expressed in high flow
arteries.23 It generates enzymatically prostacyclin
and prostaglandin E2; both are inhibitors of SMC
growth and cause vasorelaxation.25,26 COX-2 and
the iNOS are expressed in injured rat artery and are
induced by inflammatory cytokines in cultured
SMCs.60 Finally, chronic inhibition of NOS
enhances the production of prostacyclin through the
upregulation of cyclooxygenase-1.61 It is therefore
quite likely that NO and inhibitory prostaglandins
generated by high flow, injury, inflammation, or
NOS blockade act in concert to block, or at least
blunt, SMC proliferation.
SMC proliferation might require not only NOS
blockade, but also the action of growth promoting
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factors. The observation that SMC proliferation was
increased, although not significantly, in the segment of
vessel adjacent to the L-NA infusion device supports
this hypothesis. It is in this location that the vascular
occluders were placed during the surgical insertion of
the infusion device. Although we have not rigorously
studied these vessels, it is probable that compression of
the vessels transiently by the occluders produced some
injury to the endothelium and medial SMCs, and
thereby liberated factors (eg, basic fibroblast growth
factor) from the cells or caused platelet adhesion and
release of growth factors (eg, PDGF).62 We have
demonstrated that PDGF-A chain is induced in vascu-
lar grafts and iliac arteries subjected to flow switch.27
We do not know whether PDGF-AA or PDGF-AB are
growth factors in these vessels, nor do we know
whether NO affects growth factor expression. It is pos-
sible that the turnoff of the growth inhibitors (eg,
cNOS/NO, COX-2/PGE2, and PGI2) and the
induction of the growth promoting factors occur inde-
pendently in response to the switch from high to nor-
mal blood flow. When these results are taken together
with data available in the literature, it seems certain
that NOS blockade is necessary, but not sufficient for
the induction of vascular SMC growth in vivo.
We thank Tim Peterson, David Hasenstab, Sandro
Lepidi, and Holly Lea for their assistance.
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